4. Global Anti-Viral Therapies - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Anti-Viral Therapies Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing R&D Expenditures in Pharmaceutical Companies
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 High Cost of Drug Development
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Growing Emphasis on Launching Anti-Viral Agents
5.5 Impact analysis
6. Anti-Viral Therapies Market - Global Analysis
6.1 Global Anti-Viral Therapies Market Revenue Forecast And Analysis
6.2 Global Anti- Viral Therapies Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Anti - Viral Therapies Market Analysis - By Type
7.1 Overview
7.2 Anti-viral therapies market Revenue Share, by Type (2019 and 2027)
7.3 Generic Drugs
7.3.1 Overview
7.3.2 Generic Drugs: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Branded Drugs
7.4.1 Overview
7.4.2 Branded Drugs: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
8. Anti-Viral Therapies Market Analysis - By Mechanism of Action
8.1 Overview
8.2 Anti-Viral Therapies Market Revenue Share, by Mechanism Of Action (2019 and 2027)
8.3 Nucleotide Polymerase Inhibitor
8.3.1 Overview
8.3.2 Nucleotide Polymerase Inhibitor: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Reverse Transcriptase Inhibitors
8.4.1 Overview
8.4.2 Reverse Transcriptase Inhibitors: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Protease Inhibitors
8.5.1 Overview
8.5.2 Protease Inhibitors: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
9. Anti-Viral Therapies Market Analysis - By Application
9.1 Overview
9.2 Anti-Viral Therapies Market Share, by Application, 2019 and 2027, (%)
9.3 HIV
9.3.1 Overview
9.3.2 HIV: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Hepatitis
9.4.1 Overview
9.4.2 Hepatitis: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Herpes
9.5.1 Overview
9.5.2 Herpes: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
9.6 Influenza
9.6.1 Overview
9.6.2 Influenza: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
10. Anti-Viral Therapies Market - Geographic Analysis
10.1 North America: Anti-Viral Therapies Market
10.1.1 Overview
10.1.2 North America: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.1.4 North America: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.1.5 North America: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.1.6 North America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.1.7 US: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.1.7.3 US: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.1.7.4 US: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.1.8 Canada: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.1.8.3 Canada: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.1.8.4 Canada: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.1.9 Mexico: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.1.9.3 Mexico: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.1.9.4 Mexico: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2 Europe: Anti-Viral Therapies Market
10.2.1 Overview
10.2.2 Europe: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.4 Europe: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.5 Europe: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2.6 Europe: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.7.3 Germany: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.7.4 Germany: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2.8 UK: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.8.3 UK: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.8.4 UK: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2.9 France: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.9.3 France: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.9.4 France: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2.10 Spain: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.10.3 Spain: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.10.4 Spain: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.2.11 Italy: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.2.11.3 Italy: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.2.11.4 Italy: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3 Asia Pacific: Anti-Viral Therapies Market
10.3.1 Overview
10.3.2 Asia Pacific: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.4 Asia Pacific: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.5 Asia Pacific: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3.6 Asia Pacific: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.3.7 China: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.7.3 China: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.7.4 China: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3.8 Japan: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.8.3 Japan: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.8.4 Japan: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3.9 India: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.9.3 India: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.9.4 India: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3.10 South Korea: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.10.3 South Korea: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.10.4 South Korea: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.3.11 Australia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.3.11.3 Australia: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.3.11.4 Australia: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.4 Middle East & Africa: Anti-Viral Therapies Market
10.4.1 Overview
10.4.2 Middle East & Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.4.4 Middle East & Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.4.7.3 Saudi Arabia Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.4.8.3 UAE Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.4.9.3 South Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Anti-Viral Therapies Market
10.5.1 Overview
10.5.2 South and Central America: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and Central America: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.5.4 South and Central America: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.5.5 South and Central America: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.5.6 South and Central America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.5.7.3 Brazil: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.5.7.4 Brazil: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
10.5.8 Argentina: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
10.5.8.3 Argentina: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
10.5.8.4 Argentina: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Anti-Viral Therapies Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic
12. Anti-Viral Therapies Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AbbVie Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bristol-Myers Squibb Company
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson and Johnson Services, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Merck & Co., Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gilead Sciences, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AstraZeneca
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Aurobindo Pharma Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 F. HOFFMANN-LA ROCHE LTD.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments